Topic Overview
What is hemophilia?
Hemophilia is a rare
genetic bleeding disorder that almost always occurs in
males. A person has hemophilia when he or she inherits problems with certain
blood-clotting factors, making them unable to work properly.
Blood-clotting factors are needed to help stop bleeding after a cut or injury
and to prevent spontaneous bleeding. The hemophilia gene can contain many
different errors, leading to different degrees of abnormality in the amount of
clotting factor produced.
There are two major types of
hemophilia:
- Hemophilia A is caused
by a deficiency of active clotting factor VIII (8). Approximately 1 out of
every 5,000 male babies is born with hemophilia A.1
- Hemophilia B (Christmas
disease) is caused by a lack of active clotting factor IX (9). It is less
common, occurring in 1 out of every 30,000 male babies.1
Hemophilia is usually classified by how severe it is. There
are three levels of hemophilia, although they can overlap. The severity of the
disease is defined by how much clotting factor is produced and in what
situations bleeding most often occurs.
- Mild hemophilia:
Clotting factor VIII or clotting factor IX level is 5% of normal or greater.
Mild hemophilia might not be recognized unless there is excessive bleeding
after a major injury or surgery.
- Moderate hemophilia: Clotting factor VIII
or clotting factor IX level is 1% to 5% of normal. Bleeding usually follows a
fall, sprain, or strain.
- Severe hemophilia:
Clotting factor VIII or clotting factor IX level is less than 1% of normal.
Bleeding often happens one or more times a week for no apparent reason
(spontaneously).
The percentage of clotting factors stays about the same
throughout a person's life. All family members who have hemophilia usually will
have similar types.
In very rare cases, a person develops a type
of hemophilia, called acquired hemophilia, that is not inherited. If you have
acquired hemophilia, your clotting factors don't work properly because your
body makes
antibodies that attack them.
What causes hemophilia?
Hemophilia A and
hemophilia B are caused by an inherited defect in a pair of
chromosomes. The defect affects how much clotting
factor a person will produce and how the factor will function. Hemophilia is
mild when the clotting factor functions are close to normal and the amount of
clotting factor is almost normal. The less normal the function and amount of
clotting factor, the more severe the hemophilia.
What are the symptoms?
Symptoms of hemophilia are
usually first noticed during infancy or childhood. But some people who have
milder forms of hemophilia may not develop symptoms until later in life.
The following are signs of hemophilia that may be noticed shortly after
birth:
- Bleeding into the muscle, resulting in a deep
bruise after receiving a routine vitamin K shot
- Prolonged bleeding
after a boy is circumcised
- In rare cases, prolonged bleeding after
the umbilical cord is cut at birth
Other symptoms of hemophilia include:
- Bleeding into a joint or muscle that causes
pain and swelling.
- Abnormal bleeding after an injury or surgery.
- Easy bruising.
- Frequent nosebleeds.
- Blood
in the urine.
- Bleeding after dental work.
How is hemophilia diagnosed?
Blood tests can help determine whether you have hemophilia.
Genetic tests are available if you want to know whether you are a carrier
of hemophilia. (Only females can be carriers.)
What is the treatment for hemophilia?
Most people
who have hemophilia can successfully manage their bleeding problems with
clotting factor replacement therapy. Clotting factors may be injected:
- On a regular basis, to prevent bleeding
episodes.
- When needed. On-demand therapy is used before
participating in activities with a high risk for injury or when it is suspected
that bleeding has begun.
Many people who have hemophilia know when they are
bleeding, even before there are many symptoms.
Frequently Asked Questions
Learning about hemophilia: | |
Being diagnosed: | |
Getting treatment: | |
Ongoing concerns: | |
Living with hemophilia: | |
Health Tools 
Health Tools help you make wise health decisions or take action to improve your health.
Cause
Hemophilia A
and B are caused by an inherited defect in a pair of
chromosomes. Hemophilia is a
sex-linked genetic disease. It is also called an
X-linked disease because the defect is on the X chromosome. Fathers pass the
defective gene on to their daughters, but not to their sons, and mothers may be
carriers. See a picture of the
hemophilia inheritance pattern
.
Hemophilia almost always occurs in
boys. Males get the disease by inheriting the defective gene from their mother.
It is very rare for girls to have hemophilia because they must inherit a
defective gene from each parent.
The genetic defect affects how
much clotting factor a person will produce and how the factor will function.
The less normal clotting factor you have, the more severe the hemophilia.
Although hemophilia is a genetic disorder, about one-third of all
people with hemophilia have no family history of the condition.1 In these cases, hemophilia occurs spontaneously when a normal
chromosome develops an abnormality (mutation) that affects the gene that
determines the production of clotting factor. A child who inherits this
mutation may be born with hemophilia or may be a carrier. Only females can be
carriers.
Symptoms
Symptoms of
hemophilia are usually first noticed during infancy or
childhood. But some people who have milder forms of hemophilia may not have
symptoms until later in life. Although there are different types of hemophilia,
the symptoms are the same.
The following are signs of hemophilia
that may be noticed shortly after birth:
- Bleeding into the muscle, resulting in a deep
bruise after receiving a routine vitamin K shot
- Prolonged bleeding
after a male child is circumcised
- In rare cases, prolonged bleeding
after the umbilical cord is cut at birth
Other symptoms of hemophilia include:
- Bleeding into a joint or muscle that causes
pain and swelling.
- Abnormal bleeding after an injury or surgery.
- Easy bruising.
- Frequent nosebleeds.
- Blood
in the urine (hematuria).
- Bleeding after dental work.
Symptoms of bleeding into a joint (hemarthrosis)
include:
- Warmth and/or tingling in the joint during the
early stages of hemarthrosis. This is called an aura. If bleeding is not
treated, mild discomfort can progress to severe pain.
- Swelling and
inflammation in the joint, caused by repeated episodes of bleeding. If episodes
continue, it may lead to chronic pain and destruction of the
joint.
- An infant's or child's reluctance to move an arm or leg
because of bleeding into an affected joint, often first noticed when a child
begins to walk.
There are many possible symptoms of bleeding into muscle,
including:
- Bruising.
- Swelling.
- Muscle
hardening.
- Tenderness.
- Pain, especially when large
muscle groups are affected.
Occasionally, bleeding into certain muscles (forearm,
groin, or leg) puts enough pressure on arteries and nerves to cause a
complication called
compartment syndrome. A compartment syndrome is a
medical emergency that requires immediate treatment to prevent permanent damage
to muscle, bones, and other tissue. Symptoms of compartment syndrome
include:
- Weakness and paleness in the affected
extremity.
- Swelling and numbness.
- Severe pain during
movement.
- Inability to move an extremity (paralysis).
What Happens
In
hemophilia, blood does not clot properly. After
bleeding starts, it takes longer for bleeding to stop than in a person who has
blood that clots normally. A bleeding episode often begins with an injury.
Minor injuries may not always cause excessive bleeding. More severe injuries,
or injuries in the mouth, more often cause excessive bleeding and frequently
require emergency care.
Bleeding into a joint (hemarthrosis), often without an injury, is the most
common bleeding problem in people who have severe hemophilia. Bleeding usually
occurs in one joint at a time. Bleeding may develop in any joint, but knees,
elbows, and ankles are most commonly affected. Sometimes one particular joint,
called a target joint, will tend to bleed most often.
Another
common symptom of hemophilia is bleeding into a muscle (hematoma), which can be
mild or severe. Serious bleeding deep in the muscle can cause significant pain
and scarring.
Bleeding in the brain can cause serious brain damage
and possibly death. For these reasons, a person with hemophilia who has an
injury to the head usually needs urgent treatment with clotting factors.
Even with treatment, bleeding is sometimes difficult to control. Frequent
bleeding episodes or a serious injury can lead to
complications and excessive blood loss.
With the use of new
clotting factor concentrates to treat hemophilia,
people who have hemophilia now often have a normal life expectancy.2
What Increases Your Risk
Hemophilia is
an inherited genetic disease. The
risk of a child inheriting hemophilia depends on the parents' genetic
makeup.
Sometimes, a child is born with hemophilia because part of
a normal
chromosome changes (mutates) in the eggs or sperm of
one or both parents. Medical researchers do not yet know why this mutation
occurs in some people.
When To Call a Doctor
Call your health professional if
you or your child has one or more of the following symptoms of a bleeding
episode:
- Easy bruising
- A wound that does not
stop bleeding easily or continues to ooze blood
- Limited motion or
obvious swelling in a limb
If you know that your child has
hemophilia:
- Immediate treatment is needed for head
injuries, because they are very dangerous. Call
911 or take your child to the nearest
hospital emergency room when a head injury occurs. If you are trained in
treating hemophilia and have the supplies, begin infusions
first.
- Call your health professional about other types of injuries
if you are unsure whether treatment is necessary.
Watchful Waiting
Most people who have
hemophilia become skilled at recognizing early signs
of bleeding. Work with your health professional to develop a plan for what to
do if you or your child has a bleeding episode. This will allow you to start
treatment immediately when a bleeding episode is suspected.
A
child with hemophilia who is injured should be treated to prevent long-term
damage to muscles and joints.
Most people who have hemophilia are
cared for by teams who educate the person and his or her family, as well as
their health providers, teachers, and coworkers, about hemophilia. If you have
hemophilia, inform your health professionals and people you see often, such as
coworkers and close friends. Likewise, people who care for your child, such as
school officials or day care staff, should be aware that your child has
hemophilia.
People with hemophilia and their families often know a
lot about the disease and its treatment. This knowledge can help the person
with hemophilia get the right treatment quickly.
Who To See
The following health professionals can help diagnose
hemophilia:
After you or your child is diagnosed with hemophilia, one
of the following health professionals can help you develop a treatment plan or
provide urgent care:
To prepare for your appointment, see the topic Making the Most of Your Appointment.
Exams and Tests
Severe
hemophilia is usually diagnosed in early childhood or
infancy. But mild forms may not be noticed until adulthood. If a bleeding
problem is suspected, the following tests from a single blood sample will help
your health professional diagnose hemophilia, its type, and its
severity:
- Prothrombin time (PT) measures certain
clotting factors other than those related to
hemophilia. Most people with hemophilia have normal results from this test. PT
results may be abnormal if another condition is causing bleeding
problems.
- Activated partial thromboplastin time
(aPTT) measures clotting factors VIII or IX that are absent or not working
properly in people with hemophilia. If aPTT is elevated, you may have
hemophilia. But this test cannot determine which type of hemophilia (A or B) is
present or even if the defect is in factor VIII or IX. A person with hemophilia
usually has abnormal aPTT test results.
- Factor assay tests
determine the severity of hemophilia by measuring the activity levels of
factors VIII and IX in the blood, which indicate how well the factors work to
clot blood.
- Mild hemophilia:
Clotting factor VIII or IX level is 5% of normal or greater. Mild hemophilia
might not be recognized until excessive bleeding develops after a major trauma
or surgery.
- Moderate hemophilia: Clotting factor
VIII or IX level is 1% to 5% of normal. Bleeding usually follows a fall,
sprain, or strain.
- Severe hemophilia:
Clotting factor VIII or IX level is less than 1% of normal. Bleeding often
happens one or more times a week for no apparent reason.
- Mixing tests mix your plasma with normal plasma
to see if it reaches a normal level of clotting factor. If the plasma doesn't
reach a normal level, it may mean that your blood has developed
inhibitors that are interfering with clotting factor
VIII or IX. If this occurs, it may mean that you have a very rare condition
called acquired hemophilia.
Genetic screening tests
If you know that hemophilia runs in your family and you are planning to
have children, you can be tested for the
genetic defect that causes hemophilia to determine
whether you are a
carrier (only females can be carriers). This will
allow you to make informed decisions about pregnancy and prenatal care.
During pregnancy, health professionals can use
amniocentesis and
chorionic villus sampling (CVS) to test the fetus for
the genetic defect that causes hemophilia. If the fetus is found to have
hemophilia, you may choose whether you want to complete or terminate the
pregnancy. If you decide to continue with the pregnancy, your health
professional and a genetic counselor can help you learn about health issues
that affect the fetus before delivery and will affect your child after he or
she is born. With modern therapies and by being as careful as possible to
prevent bleeding, people with hemophilia can expect to live a normal life
span.2
A child can be tested for
hemophilia A after birth with a sample of blood that is taken from the
umbilical cord. Testing for hemophilia B in newborns is not effective because
newborns naturally have lower levels of clotting factor IX. Blood tests for
clotting factor IX deficiency are more effective after a child is 6 months
old.
What to think about
There
are many types of bleeding disorders that result from a deficiency in one or
more clotting factors, although most are very rare.
Von Willebrand's disease is the most common of the
inherited blood disorders. Like hemophilia, von Willebrand's disease affects
clotting factor VIII. But it does so in a different way than hemophilia, and it
affects both males and females.
Treatment Overview
Treatment of
hemophilia is determined by how severe the disease is.
Because hemophilia is a
genetic disease, treatment often begins at birth.
Hemophilia is primarily treated by replacing the absent or abnormal
clotting factors to prevent severe blood loss and
complications from bleeding.
Viruses can be transmitted through
donated blood products, although this happens very rarely. Since 1985, blood
products, including
clotting factor concentrates, have been screened for
viral diseases, such as the
human immunodeficiency virus (HIV),
hepatitis B, and
hepatitis C. Blood that is suspected of being
contaminated with these viruses is not used. Current blood-purifying procedures
destroy most viruses that are not detected during screening. Some virus risk
still exists because of
hepatitis A and parvovirus (the virus that causes
fifth disease), which are difficult to detect and
destroy because of their molecular structure. As a result, in very rare cases
some viruses are transmitted through the clotting factor
plasma products from donated blood, which can result
in complications. Plasma concentrates produced in a lab
(using recombinant
DNA technology) have almost no risk of transmitting
viruses.2
Initial treatment
If you are pregnant and know
that
hemophilia runs in your family, talk to your health
professional about hemophilia care. A diagnosis can be made at the time of
birth. Sometimes mothers do not know that they are
carriers for hemophilia, and in that case you may not
discover that your son has hemophilia until he has noticeable bruising or
bleeding following an injury. Tests will determine which form of hemophilia is
present and how severe it is.
Children and adults with mild
hemophilia may not need
clotting factor replacement, except before medical or
dental procedures or following an injury. For more severe hemophilia, clotting
factor replacement can be given intravenously. A child as young as 10 can learn
to self-administer the replacement.
Hemophilia treatment centers
are available at most large medical centers and are an excellent resource to
help you and your family get the best care for this condition. These centers
have
hematologists, nurses,
social workers,
physical therapists, and
dentists who specialize in treating people with
hemophilia.
Ongoing treatment
Clotting factors are replaced by
injecting (infusing)
clotting factor replacement into the veins. The
severity of
hemophilia determines how clotting factors are
replaced.
- Severe forms of hemophilia: Clotting factors may be replaced on a regularly scheduled
basis (prophylaxis) to prevent bleeding, or on demand in response to symptoms
of a bleeding episode or before an activity that may cause
bleeding.
- Less severe forms of hemophilia:
Clotting factors are replaced on demand, when:
- Bleeding starts, such as after an
injury.
- Bleeding is expected, such as before
surgery.
- When participating in activities that increase the risk
for bleeding, such as contact sports.
Should I have regularly scheduled or on-demand clotting factor replacement therapy for hemophilia?
What To Think About
Medications can be
used to help increase clotting factors when undergoing certain medical or
dental procedures. These are effective if you have mild hemophilia. And they
are used in combination with clotting factors if you have a more severe form of
the disease.
Most complications are successfully managed by the
injection of clotting factors. But
complications can result from treatment with clotting
factor replacement.
Chronic pain from joint damage commonly
occurs in people who have hemophilia and have one or more severe bleeding
episodes inside a joint every year.
Narcotics are the most effective medicines to relieve
acute joint pain associated with hemophilia. In some cases, joint replacement
surgery may be recommended.
Prevention
Because it is an inherited genetic disease,
hemophilia cannot be prevented. If you or any of your
immediate family members (parents or siblings) have hemophilia or are carriers
and you are thinking about having a child, you may want to talk to a health
professional who specializes in the study of inherited disorders (medical geneticist) before becoming pregnant. A
genetic counselor can tell you how likely it is that
your child will have hemophilia and how severe it might be.
If you
have hemophilia, maintain a healthy body weight to limit the stress on your
joints, which can lead to bleeding episodes. Also, talk to your doctor about
creating an exercise plan that is safe for people with hemophilia. Regular
exercise strengthens the joints and muscles, which helps prevent
bleeding.
It is especially important to prevent bleeding into the
joints, because it can result in severe disability.
Home Treatment
Home treatment for
hemophilia includes learning how to recognize when
bleeding has started, administering
clotting factors, eating well, and exercising
regularly. Learning how to care for yourself or a child with hemophilia at home
can lead to a better quality of life.
There are steps you can take
to improve your health and prevent bleeding episodes. It is especially
important to prevent bleeding into the joints, because it can result in severe
disability.
- Stay at a healthy body weight. If you are
overweight, the additional stress on joints can trigger bleeding episodes. For
more information, see the topic
Weight Management.
- Exercise with care.
Exercises that do not put excess pressure on your joints, such as swimming,
usually are recommended.
- Do not take
nonprescription medicines unless your doctor tells you
to. Avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs), such as
aspirin, ibuprofen, and Aleve, which can affect the clotting action of your
blood.
- Prevent injuries and accidents around your
home.
- Recognize bleeding episodes so that if an injury or
spontaneous bleeding occurs, you can start treatment immediately.
You may be able to treat hemophilia at home by
infusing blood-clotting factors. Discuss this option
with your health professional.
Medications
Medicines can be used in specific
situations or in combination with
clotting factor replacement to treat
hemophilia.
- Antifibrinolytic agents
prevent chemicals in the blood from breaking down blood clots. This type of
medicine is used before dental procedures and to treat nosebleeds, because it
slows bleeding in the mucous membranes. These medicines are usually used in
combination with clotting factors.
- Fibrin glue helps stop oozing of minor skin wounds in people with hemophilia A.
Fibrin glue is often used during dental procedures.
- Desmopressin acetate is used, although
rarely, to treat mild hemophilia A. This medicine releases unused
clotting factor VIII from the cells that line blood
vessels, which greatly increases the percentage of clotting factor VIII that is
in the blood. Usually, desmopressin acetate is used in addition to clotting
factor replacement. But for mild forms of hemophilia, it can be used instead of
clotting factor replacement.
Medication Choices
- Desmopressin acetate
- Antifibrinolytic agents
- Fibrin glue
What To Think About
Desmopressin, antifibrinolytic
agents, and fibrin glue do not replace
clotting factors as the major treatment for
hemophilia.
Surgery
There is no surgical treatment for
hemophilia. But the complications of hemophilia, such
as joint problems, bleeding around the brain, or swelling that causes pressure
buildup in an arm or a leg (compartment syndrome), may require
surgery.
Blood-clotting factor replacement is
needed before, during, and after any surgical procedure, including some dental
procedures.
A person who has mild hemophilia may be given an
antifibrinolytic agent or desmopressin acetate before dental procedures.
Clotting factors,
antifibrinolytic agents,
fibrin glue, and possibly
desmopressin acetate are usually used in combination
to control bleeding in the mouth.
Other Treatment
Bleeding problems caused by
hemophilia can be prevented and treated with clotting
factor replacement therapy.
Clotting factors come from blood donors (plasma-derived clotting factors) or are produced in a
laboratory (recombinant or
DNA-engineered). The amount of clotting factor needed
is determined by how severe the hemophilia is and/or the location of the
bleeding. More clotting factor is needed for surgery or bleeding in the brain
than for less serious situations, such as routine dental procedures.
Depending upon how severe your disease is, you may choose either to:
- Receive regularly scheduled infusions of
clotting factor to prevent bleeding.
- Receive clotting factor on
demand, that is, only after bleeding starts or before you participate in an
activity that will likely cause bleeding.
Should I have regularly scheduled or on-demand clotting factor replacement therapy for hemophilia?
Sometimes a person's body develops antibodies-called
inhibitors-to the injected clotting factor. People who
have severe hemophilia or who receive clotting factor replacement for the first
time are more likely to develop inhibitors, as are children. When this occurs,
specially engineered replacement clotting factors may be required. Other
treatment for clotting factor inhibitors includes therapy to suppress the
immune system (immunosuppressive therapy).
Other Treatment Choices
- Clotting factor replacement
- Treatment for people who have inhibitors
What To Think About
Gene therapy may eventually be
able to boost the body's ability to make clotting factor. Researchers have
developed genes that can cause a person to make clotting factors (for example,
factor VIII). These genes have been transplanted into people with hemophilia in
research studies. But the people could only produce a very low level of factor
VIII. And the clotting factor lasted for less than a year. But no serious side
effects were seen. Gene therapy is still a promising treatment for hemophilia,
and research is ongoing.2
Other Places To Get Help
Organizations
| National Heart, Lung, and Blood Institute
(NHLBI) |
|
P.O. Box 30105 |
| Bethesda, MD 20824-0105 |
| Phone: | (301) 592-8573 |
| Fax: | (240) 629-3246 |
| TDD: | (240) 629-3255 |
| E-mail: | nhlbiinfo@nhlbi.nih.gov |
| Web Address: | www.nhlbi.nih.gov |
| |
The U.S. National Heart, Lung, and Blood Institute (NHLBI)
information center offers information and publications about preventing and
treating heart, lung, and blood diseases. |
|
| National Hemophilia Foundation (NHF) |
| 116 West 32nd Street, 11th Floor |
| New York, NY 10001 |
| Phone: | (212) 328-3700 |
| Fax: | (212) 328-3777 |
| E-mail: | HANDI@hemophilia.org |
| Web Address: | www.hemophilia.org |
| |
The National Hemophilia Foundation (NHF) is dedicated to the cures
of inherited bleeding disorders and the prevention and treatment of their
complications through education, advocacy, and research. The NHF has chapters
throughout the country and a communications network that brings health
professionals and the public the latest news about bleeding disorders. NHF's
Web site provides information on the nature, symptoms, and treatments of many
disorders. |
|
| World Federation of Hemophilia |
| 1425 René Lévesque Boulevard West |
|
Suite 1010 |
| Montréal, QC H3G 1T7 Canada |
| Phone: | (514) 875-7944 |
| Fax: | (514) 875-8916 |
| E-mail: | wfh@wfh.org |
| Web Address: | www.wfh.org |
| |
The World Federation of Hemophilia works to introduce, improve,
and maintain care for people with hemophilia and related bleeding disorders
around the world. The WFH provides various health care development programs and
publications. The Web site provides general information on the disease, as well
as research updates. Links to other organizations and further research
resources are also listed. |
|
References
Citations
Hillman RS, et al. (2005). Hemophilia and other
intrinsic pathway defects. In RS Hillman, et al. eds., Hematology in Clinical Practice, 4th ed., chap. 32, pp.
368-379. New York: McGraw-Hill.
Roberts HR, et al. (2006). Hemophilia A and hemophilia
B. In MA Lichtman et al., eds., Williams Hematology, 7th
ed., pp. 1867-1886. New York: McGraw-Hill.
Other Works Consulted
Fischer K, et al. (2002). Prophylactic versus
on-demand treatment strategies for severe haemophilia: A comparison of costs
and long-term outcome. Haemophilia, 8(6):
745-752.
Friedman KD, Rodgers GM (2004). Coagulation disorders.
In JP Greer et al., eds., Wintrobe's Clinical Hematology, 11th ed., vol. 2, section 4, chap. 59, pp. 1619-1667.
Philadelphia: Lippincott Williams and Wilkins.
Kessler CM, Tfayli A (2003). Coagulation disorders:
Acquired and congenital. In B Furie et al., eds., Clinical Hematology and Oncology, chap. 58, pp. 498-510. Philadelphia: Churchill
Livingstone.
Credits
| Author | Robin Parks, MS |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman, MATC |
| Primary Medical Reviewer | Anne C. Poinier, MD - Internal Medicine |
| Specialist Medical Reviewer | Brian Leber, MDCM, FRCPC - Hematology |
| Last Updated | August 20, 2007 |